Circulating 25-hydroxyvitamin D3 in relation to renal cell carcinoma incidence and survival in the EPIC cohort

American Journal of Epidemiology

Volumn 180, Issue 8, 2014, Pages 810-820

  Muller, David C ^a   Fanidi, Anouar ^a   Midttun, Øivind ^b   Steffen, Annika ^c   Dossus, Laure ^d,e,f   Boutron Ruault, Marie Christine ^d,e,f   Severi, Gianluca ^g   Kühn, Tilman ^h   Katzke, Verena ^h   De La Torre, Ramón Alonso ⁱ   González, Carlos A ^j   Sánchez, María José ^k,l   Dorronsoro, Miren ^m   Santiuste, Carmen ⁿ   Barricarte, Aurelio ^l,o   Khaw, Kay Tee ^a,p   Wareham, Nick ^q   Travis, Ruth C ^r   Trichopoulou, Antonia ^s,t   Giotaki, Maria ^s   Trichopoulos, Dimitrios ^s,t,u   Palli, Domenico ^v   Krogh, Vittorio ^w   Tumino, Rosario ^x   Vineis, Paolo ^g,y   Panico, Salvatore ^z   Tjønneland, Anne ^aa   Olsen, Anja ^aa   Bueno De mesquita, H Bas ^y,ab,ac   Peeters, Petra H ^y,ac   Ljungberg, Börje ^ad   Wennberg, Maria ^ad   Weiderpass, Elisabete ^ae,af,ag,ah   Murphy, Neil ^y   Riboli, Elio ^y   Ueland, Per Magne ^ai,aj   Boeing, Heiner ^c   Brennan, Paul ^a   Johansson, Mattias ^a   more..

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b BEVITAL AS   (Norway)

^c GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

^d INSERM   (France)

^e UNIVERSITÉ PARIS SACLAY   (France)

^f INSTITUT GUSTAVE ROUSSY   (France)

^g Human Genetics Foundation   (Italy)

^h GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

ⁱ Public Health Dirctorte   (Spain)

^j CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^k Instituto de Investigación Biosanitaria de Granada   (Spain)

^l CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^m BIODONOSTIA HEALTH RESEARCH INSTITUTE   (Spain)

ⁿ DEPARTMENT OF EPIDEMIOLOGY   (Spain)

^o INSTITUTO DE SALUD PÚBLICA DE NAVARRA   (Spain)

^p UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^q UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^r UNIVERSITY OF OXFORD   (United Kingdom)

^s HELLENIC HEALTH FOUNDATION   (Greece)

^t BIOMEDICAL RESEARCH FOUNDATION   (Greece)

^u HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^v CANCER RESEARCH AND PREVENTION INSTITUTE ISPO   (Italy)

^w NATIONAL CANCER INSTITUTE   (Italy)

^x Cancer Registry and Histopathology Unit   (Italy)

^y IMPERIAL COLLEGE LONDON   (United Kingdom)

^z UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^aa DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

^ab NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^ac UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^ad UMEÅ UNIVERSITY   (Sweden)

^ae UNIVERSITY OF TROMSØ   (Norway)

^af CANCER REGISTRY OF NORWAY   (Norway)

^ag KAROLINSKA INSTITUTE   (Sweden)

^ah FOLKHÄLSAN RESEARCH CENTER   (Finland)

^ai UNIVERSITY OF BERGEN   (Norway)

^aj HAUKELAND UNIVERSITY HOSPITAL   (Norway)

more..

Author keywords

Nested case control study; Prospective study; Renal cell carcinoma; Vitamin D

Indexed keywords

CALCIFEDIOL; COTININE;

ALCOHOL; BLOOD; CANCER; CARDIOVASCULAR SYSTEM; CELLS AND CELL COMPONENTS; COHORT ANALYSIS; DISEASE INCIDENCE; FOOD INTAKE; HEALTH RISK; MORTALITY RISK; SMOKING; SURVIVAL; VITAMIN;

ADULT; AGE; AGED; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; CANCER INCIDENCE; CANCER RISK; CANCER SURVIVAL; COHORT ANALYSIS; DEATH; DEMOGRAPHY; FEMALE; FLEXIBLE PARAMETRIC SURVIVAL MODEL; GENDER; HUMAN; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; PROPORTIONAL HAZARDS MODEL; SEASONAL VARIATION; SMOKING; STATISTICAL ANALYSIS; BLOOD; CARCINOMA, RENAL CELL; CAUCASIAN; DRINKING BEHAVIOR; EPIDEMIOLOGY; INCIDENCE; MIDDLE AGED; MORTALITY; PROSPECTIVE STUDY; RISK; RISK FACTOR; SEX DIFFERENCE; STATISTICAL MODEL;

AGE FACTORS; AGED; ALCOHOL DRINKING; BODY MASS INDEX; CALCIFEDIOL; CARCINOMA, RENAL CELL; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; INCIDENCE; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS; SMOKING;

EID: 84921772475     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwu204     Document Type: Article

References (35)

1. Jenab M, Bueno-de Mesquita HB, Ferrari P, et al. Association between pre-diagnostic circulating vitamin D concentration and risk of colorectal cancer in European populations: a nested case-control study. BMJ. 2010;340:b5500.
2. Touvier M, Chan DS, Lau R, et al. Meta-analyses of vitamin D intake, 25-hydroxyvitamin D status, vitamin D receptor polymorphisms, and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev. 2011;20(5):1003-1016.
3. Holick MF. McCollum Award Lecture, 1994: vitamin D-new horizons for the 21st century. Am J Clin Nutr. 1994;60(4):619-630.
4. Ferlay J, Shin HR, Bray F, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127(12):2893-2917.
5. Grant WB, Garland CF. The association of solar ultraviolet B (UVB) with reducing risk of cancer: multifactorial ecologic analysis of geographic variation in age-adjusted cancer mortality rates. Anticancer Res. 2006;26(4 A):2687-2699.
6. Mohr SB, Gorham ED, Garland CF, et al. Are low ultraviolet B and high animal protein intake associated with risk of renal cancer? Int J Cancer. 2006;119(11):2705-2709.
7. Ginde AA, Liu MC, Camargo CA Jr, et al. Demographic differences and trends of vitamin D insufficiency in the US population, 1988-2004. Arch Intern Med. 2009;169(6):626-632.
8. Lipworth L, McLaughlin JK, Tarone RE, et al. Renal cancer paradox: higher incidence but not higher mortality among African-Americans. Eur J Cancer Prev. 2011;20(4):331-333.
9. Afzal S, Bojesen SE, Nordestgaard BG. Low plasma 25-hydroxyvitamin D and risk of tobacco-related cancer. Clin Chem. 2013;59(5):771-780.
10. Gallicchio L, Moore LE, Stevens VL, et al. Circulating 25-hydroxyvitamin D and risk of kidney cancer: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers. Am J Epidemiol. 2010;172(1):47-57.
11. Riboli E, Hunt KJ, Slimani N, et al. European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection. Public Health Nutr. 2002;5(6 B):1113-1124.
12. Midttun Ø, Ueland PM. Determination of vitamins A, D and E in a small volume of human plasma by a high-throughput method based on liquid chromatography/tandem mass spectrometry. Rapid Commun Mass Spectrom. 2011;25(14):1942-1948.
13. Royston P, Parmar MK. Flexible parametric proportionalhazards and proportional-odds models for censored survival data, with application to prognostic modelling and estimation of treatment effects. Stat Med. 2002;21(15):2175-2197.
14. R Core Team. R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing: Vienna, Austria; 2013.
15. Carstensen B, Plummer M, Laara E, et al. Epi: A package for statistical analysis in epidemiology. R package version 1.1.49. 2013.
16. Gallicchio L, Helzlsouer KJ, Chow WH, et al. Circulating 25-hydroxyvitamin D and the risk of rarer cancers: design and methods of the Cohort Consortium Vitamin D Pooling Project of Rarer Cancers. Am J Epidemiol. 2010;172(1):10-20.
17. Bertrand KA, Giovannucci E, Liu Y, et al. Determinants of plasma 25-hydroxyvitamin D and development of prediction models in three US cohorts. Br J Nutr. 2012;108(10):1889-1896.
18. Giovannucci E, Liu Y, Rimm EB, et al. Prospective study of predictors of vitamin D status and cancer incidence and mortality in men. J Natl Cancer Inst. 2006;98(7):451-459.
19. Joh HK, Giovannucci EL, Bertrand KA, et al. Predicted plasma 25-hydroxyvitamin D and risk of renal cell cancer. J Natl Cancer Inst. 2013;105(10):726-732.
20. Bosetti C, Scotti L, Maso LD, et al. Micronutrients and the risk of renal cell cancer: a case-control study from Italy. Int J Cancer. 2007;120(4):892-896.
21. Prineas RJ, Folsom AR, Zhang ZM, et al. Nutrition and other risk factors for renal cell carcinoma in postmenopausal women. Epidemiology. 1997;8(1):31-36.
22. Wilson RT, Wang J, Chinchilli V, et al. Fish, vitamin D, and flavonoids in relation to renal cell cancer among smokers. Am J Epidemiol. 2009;170(6):717-729.
23. Giovannucci E. The epidemiology of vitamin D and cancer incidence and mortality: a review (United States). Cancer Causes Control. 2005;16(2):83-95.
24. 3 agents in murine renal cell carcinoma. J Urol. 1998;160(1):247-251.
25. 3 on the growth of the renal carcinoma cell line. Kidney Int. 1986;29(4):834-840.
26. Schöttker B, Haug U, Schomburg L, et al. Strong associations of 25-hydroxyvitamin D concentrations with all-cause, cardiovascular, cancer, and respiratory disease mortality in a large cohort study. Am J Clin Nutr. 2013;97(4):782-793.
27. Virtanen JK, Nurmi T, Voutilainen S, et al. Association of serum 25-hydroxyvitamin D with the risk of death in a general older population in Finland. Eur J Nutr. 2011;50(5):305-312.
28. Hutchinson MS, Grimnes G, Joakimsen RM, et al. Low serum 25-hydroxyvitamin D levels are associated with increased all-cause mortality risk in a general population: the Tromsø Study. Eur J Endocrinol. 2010;162(5):935-942.
29. Szulc P, Claustrat B, Delmas PD. Serum concentrations of 17β-E2 and 25-hydroxycholecalciferol (25OHD) in relation to all-cause mortality in older men-the MINOS Study. Clin Endocrinol (Oxf). 2009;71(4):594-602.
30. Semba RD, Houston DK, Ferrucci L, et al. Low serum 25-hydroxyvitamin D concentrations are associated with greater all-cause mortality in older community-dwelling women. Nutr Res. 2009;29(8):525-530.
31. Pilz S, Dobnig H, Nijpels G, et al. Vitamin D and mortality in older men and women. Clin Endocrinol (Oxf). 2009;71(5):666-672.
32. Melamed ML, Michos ED, PostW, et al. 25-hydroxyvitamin D levels and the risk of mortality in the general population. Arch Intern Med. 2008;168(15):1629-1637.
33. Jia X, Aucott LS, McNeill G. Nutritional status and subsequent all-cause mortality in men and women aged 75 years or over living in the community. Br J Nutr. 2007;98(3):593-599.
34. Michaëlsson K, Baron JA, Snellman G, et al. Plasma vitamin D and mortality in older men: a community-based prospective cohort study. Am J Clin Nutr. 2010;92(4):841-848.
35. Major JM, Graubard BI, Dodd KW, et al. Variability and reproducibility of circulating vitamin D in a nationwide U. S. population. J Clin Endocrinol Metab. 2013;98(1):97-104.